According to TechFlow, on June 26, Opyl Limited, an artificial intelligence biotech company listed on the Australian Stock Exchange, announced the adoption of a Bitcoin reserve strategy to cope with financial pressure. The company purchased about 2 Bitcoins through the DigitalX Bitcoin ETF, worth about $214,500.
Opyl said the move was aimed at strengthening "treasury diversification" and creating shareholder value. It is worth noting that Opyl had only $41,700 in cash at the end of the March quarter, which was less than a month's supply. After the announcement, Opyl's stock price rose by more than 47% that day.